James Shin
Stock Analyst at Deutsche Bank
(2.68)
# 1,916
Out of 5,182 analysts
25
Total ratings
58.33%
Success rate
18.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintains: Buy | $51 → $55 | $25.71 | +113.92% | 2 | Mar 25, 2026 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $931.09 | +38.01% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $119.28 | -6.94% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $10.25 | -2.44% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $138.80 | -13.54% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $340.00 | -10.29% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $93.69 | -35.96% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $57.67 | -21.97% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $17.99 | +233.52% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $206.37 | -27.32% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $800 | $760.27 | +5.23% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.36 | +635.29% | 1 | Nov 9, 2023 |
Sutro Biopharma
Mar 25, 2026
Maintains: Buy
Price Target: $51 → $55
Current: $25.71
Upside: +113.92%
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $931.09
Upside: +38.01%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $119.28
Upside: -6.94%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.25
Upside: -2.44%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $138.80
Upside: -13.54%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $340.00
Upside: -10.29%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $93.69
Upside: -35.96%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $57.67
Upside: -21.97%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $17.99
Upside: +233.52%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $206.37
Upside: -27.32%
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $760.27
Upside: +5.23%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.36
Upside: +635.29%